Veterinary Medicines

Advantix Spot-on solution for dogs up to 4 kg

Authorised
  • Permethrin (40:60)
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
ADVANTIX SPOT-ON-DOG 40+200MG/0,4ML ΔΙΑΛΥΜΑ ΓΙΑ ΕΠΙΧΥΣΗ ΣΕ ΣΗΜΕΙΟ
Advantix Spot-on solution for dogs up to 4 kg
Active substance:
  • Permethrin (40:60)
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Permethrin (40:60)
    200.00
    milligram(s)
    /
    1.00
    Pipette
  • Imidacloprid
    40.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:
  • Pack with 24 short-neck tube pipettes
  • Pack with 6 short-neck tube pipettes
  • Pack with 4 short-neck tube pipettes
  • Pack with 3 short-neck tube pipettes
  • Pack with 2 short-neck tube pipettes
  • Pack with 1 short-neck tube pipette

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 3639/19-01-2010/K-0152701
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0113/001
Concerned member states:
  • Austria
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Netherlands
  • Norway
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 5/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."